Geode Capital Management’s Achieve Life Sciences ACHV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $819K | Sell |
|
|||||
|
2025
Q1 | $2.05M | Buy |
|
|||||
|
2024
Q4 | $2.66M | Buy |
|
|||||
|
2024
Q3 | $3.55M | Buy |
|
|||||
|
2024
Q2 | $3.29M | Buy |
|
|||||
|
2024
Q1 | $940K | Buy |
|
|||||
|
2023
Q4 | $762K | Hold |
|
|||||
|
2023
Q3 | $795K | Buy |
|
|||||
|
2023
Q2 | $842K | Sell |
|
|||||
|
2023
Q1 | $1.23M | Buy |
|
|||||
|
2022
Q4 | $210K | Sell |
|
|||||
|
2022
Q3 | $282K | Hold |
|
|||||
|
2022
Q2 | $417K | Hold |
|
|||||
|
2022
Q1 | $647K | Hold |
|
|||||
|
2021
Q4 | $665K | Hold |
|
|||||
|
2021
Q3 | $727K | Buy |
|
|||||
|
2021
Q2 | $508K | Buy |
|
|||||
|
2021
Q1 | $339K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $14K | Hold |
|
|||||
|
2020
Q1 | $11K | Hold |
|
|||||
|
2019
Q4 | $19K | Sell |
|
|||||
|
2019
Q3 | $61K | Buy |
|
|||||
|
2019
Q2 | $68K | Hold |
|
|||||
|
2019
Q1 | $114K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $27K | Hold |
|
|||||
|
2017
Q2 | $53K | Sell |
|
|||||
|
2017
Q1 | $67K | Hold |
|
|||||
|
2016
Q4 | $75K | Hold |
|
|||||
|
2016
Q3 | $76K | Hold |
|
|||||
|
2016
Q2 | $151K | Buy |
|
|||||
|
2016
Q1 | $77 | Hold |
|
|||||
|
2015
Q4 | $137K | Hold |
|
|||||
|
2015
Q3 | $252K | Buy |
|
|||||
|
2015
Q2 | $236K | Buy |
|
|||||
|
2015
Q1 | $139K | Hold |
|
|||||
|
2014
Q4 | $148K | Hold |
|
|||||
|
2014
Q3 | $172K | Sell |
|
|||||
|
2014
Q2 | $243K | Sell |
|
|||||
|
2014
Q1 | $868K | Buy |
|
|||||
|
2013
Q4 | $431K | Hold |
|
|||||
|
2013
Q3 | $499K | Buy |
|
|||||
|
2013
Q2 | $504K | Buy |
|